Methods Mentioned
BETA
biopsies
biopsy
Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Cancer Control : Journal of the Moffitt Cancer Center
C L KaneR L Sandin
The Lancet Infectious Diseases
Tang Ngee ShimPhilip W Preston
Journal of the American Academy of Dermatology
D R Gutknecht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
P K SranS M Whitcup
International Journal of Dermatology
I C ValenciaF A Kerdel